ARTPred wants to fundamentally change fertility-care worldwide.
ARTPred is developing the first Fertility Microbiome Profiling test (ReceptIVFity). ReceptIVFity is a personalized, minimally invasive test that predicts IVF outcome.
Our fertility test is based on urinary and vaginal microbiome profiling.
It is our vision to fundamentally improve fertility-care worldwide by making our technologies available to every IVF patient.